• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LDX 3.03% 3.4¢

LUMOS DIAGNOSTICS HOLDINGS LIMITED - Discussion

Lumos Diagnostics Holdings Ltd is an Australia-based company, which specializes in... Lumos Diagnostics Holdings Ltd is an Australia-based company, which specializes in point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions. The Company offers customized assay development and manufacturing services for POC tests and digital reader platforms. It also directly develops, manufactures, and commercializes, Lumos-branded POC tests that target infectious and inflammatory diseases. The Company’s products include FEBRIDX, COVIDX, and ViraDx. FebriDx is a point-of-care test which can be used to detect and aid in differentiating bacterial from viral acute respiratory infections. ViraDx is a point-of-care, three-in-one COVID-19/Flu A/Flu B rapid antigen test. Its services include assay development, reader development, cloud and data, and manufacturing. It manages the full development program for point-of-care (POC) assays, from sourcing and/or generation of reagents, right through to verification and validation.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Lumos Diagnostics Holdings Limited

Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX News
(20min delay)
Last
3.4¢
Change
0.001(3.03%)
Mkt cap ! $18.57M
Open High Low Value Volume
3.4¢ 3.5¢ 3.3¢ $62.34K 1.833M

Buyers (Bids)

No. Vol. Price($)
1 1014528 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 1666761 1
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
Last
3.4¢
  Change
0.001 ( 3.03 %)
Open High Low Volume
3.3¢ 3.5¢ 3.3¢ 1245583
Last updated 15.59pm 22/11/2024 ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.